UNSPSC 51392802: Amezinium metilsulfate

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H12N3O.CH3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03NR868ICX, chemically known as pyridazinium, 4-amino-6-methoxy-1-phenyl-, methyl sulfate but generally known as amezinium methyl sulfate, which bears US NIH Compound Identifier 71926. European Medicines Agency schedules Amezinium metilsulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05412MIG.

UNSPSC 51392802 Amezinium metilsulfate is a Commodity code that carries little relevance to current state and local procurement activity. The recent opportunities tagged under this code—a Seminole County, Florida IFB for naloxone and drug deactivation systems and a Texas Health and Human Services Commission RFI for direct-to-manufacturer prescription programs—do not align with amezinium metilsulfate, a cardiovascular agent used to treat hypotension. The naloxone solicitation addresses opioid-overdose reversal and safe drug disposal, and the Texas RFI explores pharmacy benefit management and prescription fulfillment channels; neither involves the specific pharmaceutical product named in the code. The mismatch suggests either miscoding in the source data or that amezinium metilsulfate, while cataloged in UNSPSC, does not drive measurable procurement volume in state and local markets.

No representative state or local opportunities directly soliciting amezinium metilsulfate appear in the recent records. Buyers interested in this pharmaceutical are unlikely to find decision-relevant activity under this code, and vendors should verify whether state and local health departments, Medicaid agencies, or purchasing cooperatives use this code in practice or rely on alternative sourcing mechanisms such as group purchasing organizations, prime vendor contracts, or federal Supply Schedule pricing.